SCHEMBL9679685

SCHEMBL9679685

CC(C)c1cccc(C(C)C)c1NC(=O)CN(CC1(c2ccccc2)CCCC1)C(=O)Nc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 5/20 0.48
SOAT2 O75908 3/20 0.48
ACAT1 P24752 1/20 0.48
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.41
NMBR P28336 1/20 0.40
LMNA P02545 2/20 0.39
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
EP300 Q09472 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9680743 0.95 SOAT1 (0.51) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL9679354 0.90 SOAT1 (0.47) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL9679702 0.87 SOAT1 (0.49) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL9679689 0.85 RECQL (0.45) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL9765050 0.82 SOAT1 (0.51) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL9765049 0.79 SOAT2 (0.48) SOAT1SOAT2ACAT1
SCHEMBL9679390 0.79 ALDH1A1 (0.58) SOAT1SOAT2KMT2AMEN1SMN1; SMN2
SCHEMBL9678897 0.78 SOAT1 (0.57) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL3409396 0.77 KMT2A (0.43) SOAT1SOAT2ACAT1KMT2AMEN1
SCHEMBL9680651 0.76 THRB (0.48) SOAT1SOAT2ACAT1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed